viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Diamorphine hydrochloride
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Diamorphine hydrochloride for injection
Suurbritannia
Diaphin
Sveits
Viited : Diamorphine hydrochloride
tüüp
avaldamine
339
ajaleht
Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.
Stability of heroin hydrochloride in infusion devices and containers for intravenous administration.
Am J Hosp Pharm 1990 ; 47: 377-381.
484
ajaleht
Northcott M, Allsopp MA, Powell H, Sewell GJ.
The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions.
J Clin Pharm Ther 1991 ; 16: 123-129.
506
ajaleht
Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P.
Diamorphine stability in aqueous solution for subcutaneous infusion.
J Pharm Pharmacol 1989 ; 41: 275-277.
512
ajaleht
Barnes AR, Nash S.
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Pharm World Sci 1995 ; 17: 87-92.
779
ajaleht
Collins AJ, Abethell JA, Holmes SG, Rain R.
Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration.
J Pharm Pharmacol 1986 ; 38: 51P.
788
ajaleht
Regnard CFB, Mannix K.
Subcutaneous drug compatibility in palliative care.
Lancet 1989 ; 2 (8670): 1044-1045.
1230
ajaleht
Regnard C, Pashley S, Westrope F.
Anti-emetic / diamorphine mixture compatibility in infusion pumps.
Br J Pharm Pract 1986 ; 8: 218-220.
1232
ajaleht
Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1288
ajaleht
Allwood MC, Brown PW, Lee M.
Stability of injections containing diamorphine and midazolam in plastic syringes.
Int J Pharm Pract 1994 ; 3: 57-59.
1292
ajaleht
Grassby PF, Roberts DE.
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Int J Pharm Pract 1995 ; 3: 174-177.
1385
ajaleht
Kirk B, Hain WR.
Diamorphine injection BP incompatibility.
Pharm J 1985 ; 235: 171.
1388
ajaleht
Page J, Hudson S.
Diamorphine hydrochloride compatibility with saline.
Pharm J 1982 ; 228: 238-239.
1886
ajaleht
Allwood MC.
The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes.
Palliative Med 1991 ; 5: 330-333.
2051
ajaleht
Sanchez del Aguila MJ, Jones MF, Vohra A.
Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability.
Br J Anaesth 2003 ; 90: 179-182.
2307
ajaleht
Kreeger L, Cowin P, Noble-Gresty J, Naysmith A.
Epidural diamorphine and bupivacaine stability study.
Palliative Med 1995 ; 9, 4: 315-318.
2308
ajaleht
Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M.
Stability of premixed syringes of diamorphine and hyperbaric bupivacaine.
Int J Obstet Anesth 2005 ; 14, 4: 284-287.
2404
ajaleht
Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J.
The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes
Palliative Med 2000 ; 14: 205-208.
3184
Labor
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
CP Pharmaceuticals 2005
3504
Labor
Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012
Mentions Légales